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Aim" To review outcome of 40 consecutive infrapopliteal percutaneous transluminaI angioplasty (PTA) procedures 
performed over a 65 month period. 
Chief outcome measures: The indication for PTA was intermittent claudication in 20 (50%) cases and rest pain, 
ulceration or gangrene in the remainder. 
Results: There was one technical failure; the remaining 39 limbs were all clinically improved by 24 h and this improvement 
was maintained at 3 months in 36 (90%). There were no deaths nor limb loss related to PTA and 2 embolic complications 
were successfully treated percutaneously. The primary and secondary symptomatic patencies at 24 months were 59 and 
79% respectively. The actuarial limb salvage rate at 1 year for the 20 limbs presenting with critical ischaemia was 77%, 
and 10 of the 14 procedures performed for ulceration or gangrene resulted in healing with only minor surgical 
intervention. 
Conclusions: With modern endovascular techniques, infrapopliteal PTA is a safe, worthwhile and durable procedure. 
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Introduction 
Although percutaneous transluminal angioplasty 
(PTA) of the iliac, femoral and popliteal arteries is a 
well established therapeutic option in peripheral 
vascular disease, 1 experience with infrapopliteal PTA 
has been more limited and its role remains less well 
defined. This is because multiple lesions are a com- 
mon finding in the infrapopliteal vessels and there has 
been the concern that failed PTA at this level could 
jeopardise subsequent bypass urgery. 2'3 
Dotter and Judkins 4 were the first to report 
dilatation of tibial artery stenoses with a series of 
concentric tapered catheters that were passed over 
each other. However, forward shearing forces caused 
vessel wall dissection and resulted in a high incidence 
of embolisation and reocclusion. Further experience of
infrapopliteal PTA using tapered catheters led to a 
lower incidence of complications, but a poor long- 
term patency. 5-7 The advent of coronary artery PTA 
triggered a number of technological dvances that 
facilitated infrapopliteal ngioplasty. These advances 
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All infrapopliteal PTA procedures performed by a 
single vascular adiologist (A.B.) during a 65-month 
period (November 1986 to April 1992) were reviewed. 
Details of the techniques used have previously been 
describedJ 8 After diagnostic arteriograph~ the ipsi- 
lateral common femoral artery was cannulated ante- 
gradely and a size 5 F (Van Andel type, Cook Ltd, 
Letchworth, U.K.) predilating catheter introduced. 
Prior to crossing an infrapopliteal lesion heparin (5000 
Units) and 12.5 mg of tolazoline were injected into the 
included small strong low profile balloons, steerable 
hydrophilic guidewires, road mapping facilities and 
the use of vasodilators to overcome arterial spasm. 
Although a number of reports using these new 
techniques have appeared since 1988, 2'3'8-14 only a 
few 15-17 have provided data on long-term actuarial 
patency rates. The purpose of this study therefore was 
to review our experience of infrapopliteal PTA and 
document the intermediate-term cumulative patency. 
Patients and Methods 
Patients and PTA technique 
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artery. The lesions were crossed using steerable 
hydrophilic angled guide wires ranging in diameter 
from 0.05 to 0.09cm (Terumo, Tokyo, Japan, or 
Schneider, Zurich, Switzerland). Having crossed the 
lesion, the Van Andel catheter was removed and 
replaced with a balloon angioplasty catheter 
(Schneider) that ranged in diameter 2 to 4ram. 
Dilatation was achieved by inflation at 10 atmospheres 
for 15 s and if there was a residual stenosis of > 30%, 
then the dilatation was repeated. If spasm developed, 
100~g boluses of nitroglycerine were administered 
intraarterially. All patients were commenced on aspi- 
rin (150 mg) the morning of angioplasty and this was 
continued for a minimum of 3 months after successful 
recanalisation. Neither intravenous nor oral anti- 
coagulation were used after PTA. 
In patients with critical ischaemia nd a single 
calf vessel that was stenosed or occluded then PTA 
was attempted. However, in claudicants with a single 
calf vessel PTA was not attempted in case a complica- 
tion converted a claudicant to a critical ischaemic. 
Definitions of outcome and data analysis 
Success, failure, complications and long-term patency 
were analysed according to the guidelines provided 
by the Society of Vascular Surgery and the Inter- 
national Society for Cardiovascular Surgery. ~9-21 Tech- 
nical success was defined as recanalisation with 30% 
or less residual stenosis and antegrade flow at the 
conclusion of the procedure. Major complications 
were defined as those that altered the patient's clinical 
state, whereas minor complications did not. Patients 
were examined after the procedure at 24h, 1, 3, 6, 9, 12 
months and thereafter at 6-monthly intervals. Haemo- 
dynamic patency required that the ankle brachial 
pressure index (ABPI), measured in the angioplastied 
arterN rose by > 0.10 within 24 h and did not fall more 
than 0.15 from the post-procedure l vel or that the 
angioplastied segment was patent on repeat arteriog- 
raphy. Symptomatic patency required that claudica- 
tion distance improved by at least 50%, the resolution 
of rest pain or healing of ulcers and minor amputa- 
tions. Primary patency required that the affected limb 
had been treated at a single angioplasty session, 
secondary patency permitted further angioplasty pro- 
cedures on the affected limb. 
Patency was computed (Systat Survival package; 
Systat, London, U.K.) using the Kaplan-Meier method 
of life table analysis 22 and compared with the Mantel- 
Haenzel log-rank testy  p rates of 0.05 or less were 
considered significant (confidence intervals are not 
produced by the log rank test I have used). Standard 
error calculations were performed using the Green- 
wood formula. 24 Patency calculations were based on 
the number of procedures performed, not the number 
of patients. Patients who died were censored at their 
last follow-up visit, no patients were lost to follow-up 
during the study. The minimum follow up was 3 
months, the maximum 60 months. 
Results 
Patient and procedure details 
Thirty-eight patients underwent 40 infrapopliteal PTA 
procedures during the study period. The median 
(range) age was 74 (44-87) years, 30 patients were 
male. Risk factors for atherosclerosis included: smok- 
ing 11 (29%); diabetes 17 (45%); and hypertension 15 
(40%). Associated symptomatic oronary artery dis- 
ease was present in 15 (39%) patients and cer- 
ebrovascular disease in nine (24%) patients. The 
indication for PTA was intermittent claudication in 20 
(50%), rest pain alone six (15%), ulceration four (10%), 
and gangrene 10 (25%). The median (range) ABPI at 
presentation was 0.55 (0.26-0.84). 
Thirty-three (83%) of the 40 infrapopliteal proce- 
dures were for stenoses (Fig. 1) and seven (17%) were 
for occlusions (Fig. 2). The median (range) lesion 
length was 10ram (2-80). Twenty-one procedures 
(52%) were to infrapopliteal vessels alone, 16 (40%) 
included one other arterial segment (one common 
femoral artery, 13 superficial femoral arteries and two 
Fig. 1. Stenosis of the right proximal nterior tibial artery before (A)
and after (B) successful PTA. 
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were distal embolisation. In each case the emboli were 
successfully retrieved by percutaneous a piration and 
there were no adverse sequelae. 
Fig. 2. Two centimetre occlusion of the left distal peroneal artery 
before (A) and after (B) successful PTA. 
popliteal arteries), and three (8%) included two other 
arterial segments (one external iliac + superficial 
femoral artery and two superficial femoral + popliteal 
arteries). Seventeen (42%) procedures were to the 
anterior tibial artery alone, eight (20%) to the tibioper- 
oneal trunk, seven (18%) to the peroneal arter3~ four 
(10%) to the posterior tibial arter3~ and four (10%) to 
multiple infrapopliteal vessels. In six cases, PTA was 
performed on the run-off artery distal to a patent 
bypass graft which was identified as failing on graft 
surveillance. 
Technical success rate andcomplications 
Technical success was achieved in 39/40 (98%) proce- 
dures. The one technical failure occurred in an anterior 
tibial artery with multiple stenoses and no other 
patent calf vessels. This patient presented with rest 
pain and ulceration and subsequently required a 
below-knee amputation. The 30-day mortality was 
zero and there were no limbs lost as a consequence of
PTA. There were two major complications (5%), both 
Outcome and patency 
The median (range) post procedure ABPI was 0.84 
(0.42-1.00), representing a median (range) increase of 
0.26 (0.00-0.59). Thirty-eight (98%) limbs had 
improved clinically by 24 h and this improvement was 
maintained at 3 months in 36 (90%). Ten of the 14 
procedures performed for ulceration or gangrene 
resulted in healing with only minor surgical inter- 
vention. The primary actuarial symptomatic and 
haemodynamic patencies for all procedures, including 
the technical failure, are shown in Fig. 3. Primary 
symptomatic patency at 2 years was 59% and the 
haemodynamic patency was 68%. There was not a 
significant difference in haemodynamic patency at 1 
year between limbs that had undergone infrapopliteal 
angioplasty alone (63%, no. at risk = 6, S.E.M. = 11%) 
and those with angioplasty of additional arterial 
segments (75%, no. at risk= 10, S.E.M.=9%), 
(p = 0.39, log rank test). The 1-year cumulative limb 
salvage rate in the 20 patients with rest pain, ulcera- 
tion or gangrene was 77% (no. of limbs at risk at 1 
year -- 10, S.E.M. = 9.8%). 
There were 12 symptomatic failures after the 39 
technically successful procedures. Five of these fail- 
ures occurred in claudicants, three of whom under- 












0 I I 
1 3 6 9 12 18 24 
Time after angioplasty (months) 
No. at risk 
Symptomatic 40 39 37 33 22 14 10 
Haemodynamic 40 39 37 33 23 16 12 
Fig. 3. Cumulative symptomatic ( ) and haemodynamic ( ...... )
patency rates after infrapopliteal PTA. The S.E.M. is < 10% at all 
time points for the two curves and the analysis includes the 
immediate technical failures. 
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one had no further procedure. Four of the sympto- 
matic failures in the seven patients with rest pain, 
ulceration or gangrene were treated by further suc- 
cessful PTA, one limb required an above-knee ampu- 
tation and the remaining two patients who presented 
with rest pain alone, were treated with analgesics. In 
total therefore, seven of the 12 symptomatic failures 
were treated by repeat angioplasty and this resulted in 
a 2-year secondary symptomatic patency of 79% 
(number of limbs at risk at 2 years = 10, 
S.E.M. = 10%). 
Discussion 
The high technical success rate and low incidence of 
complications in this study confirms the findings of 
previous reports of infrapopliteal PTA. The major 
complication rate calculated from the available lit- 
erature 2'3'7-17 in which a total of 781 procedures have 
been reported is 66 (8%). Urgent surgery was needed 
in only 15 (2%) cases and over half of these were for 
groin haematomas. There has been only one death and 
one limb loss reported that have resulted irectly from 
infrapopliteal PTA. These data clearly demonstrate 
that lesions in the crural vessels can be reached, 
crossed and dilated successfully and safely with 
modern endovascular technology. Furthermore, there 
is little evidence in these figures to support the 
concern that these procedures may prejudice sub- 
sequent bypass surgery. In fact, in our series, infra- 
popliteal PTA was used in six cases to improve the 
outcome of bypass surgery when applied to the run- 
off of "at risk" grafts. 
In the present study, 48% of infrapopliteal proce- 
dures also involved PTA of a proximal arterial 
8 11 12 15 16 segment. This is a common event . . . .  and indeed 
in one series, 17 88% of infrapopliteal procedures were 
accompanied by a proximal PTA. Although the pres- 
ence of a proximal PTA makes the separate ffect of 
tibial PTA hard to analyse we have tried to overcome 
this by measuring the ABPI using the angioplastied 
tibial vessel. The advent of colour-coded Duplex 
should allow a more accurate, non-invasive assess- 
ment of tibial artery patency in future studies. 
The low morbidity and mortality of infrapopliteal 
PTA makes it an ideal first line therapy for patients 
with critical ischaemia and a suitable lesion. The 
haemodynamic patency rate of 68% at 2 years in this 
study and of 65% at 3 years in the series reported by 
Horvath et al. 15 demonstrate that the results are 
durable. Although it is not possible to make direct 
comparisons, these patency rates compare favourably 
with those in a recent randomised multi-centre study 
of femorocrural vein bypass grafts which reported a 
secondary patency rate at 3 years of 68% for in situ 
grafts and 66% for reversed grafts, z5 The limb salvage 
rates; 77% at 2 years PTA, 78% in situ grafts at 3 years 
and 87% reversed grafts at 3 years are also compara- 
ble. However the distal bypass procedures were 
associated with an in-hospital mortality rate of 6% 26 
compared with 0.1% for PTA. 
Although the use of infrapopliteal PTA in patients 
with claudication is controversial, a number of authors 
have recommended this approach. 12'15'16 We feel that 
the low morbidity reported in this series supports this 
policy. All of our claudicants are initially managed 
conservatively, being encouraged to exercise and stop 
smoking. 27 Only patients who deteriorate or remain 
significantly troubled by their claudication are 
referred for angiography. All of the patients in this 
study experienced claudication at less than 100 yards. 
The PTA procedure is usually performed at the same 
time as this diagnostic angiogram and the entire 
procedure rarely takes more than 60 rain. This reduces 
the additional risk of repeat procedures for these 
patients whilst providing effective treatment of their 
symptoms. 
Because of the relatively small numbers of 
patients in this and other studies of infrapopliteal PTA 
it is not possible to determine the influence of factors 
such as diabetes, multiple lesions and lesion length on 
outcome. Thus although the technical feasibility, 
safety and results of infrapopliteal PTA are becoming 
increasingly apparent here is now a need to inves- 
tigate the factors influencing long-term patency so that 
rational decisions concerning patient selection can be 
made. 
In conclusion, we have found infrapopliteal PTA 
to be a safe procedure with only two embolic 
complications in this series, both of which were 
aspirated percutaneously. The symptomatic patency 
rate of 59% at 2 years and limb salvage of 77% 
compare favourably with the results of bypass urgery 
and confirm the durability of this procedure. 
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